ArticleIndian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
Survival Rates and Predictors of Mortality in Lung Cancer: A Multi-Centre Study in Kerala.
Article in Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is a major health problem in India and accounts for 5.9% of all cancers and 8.1% of all cancer-related deaths. Survival analysis studies are scarce in India as they require long-term follow-up and a good database. Therefore, the present study was conducted to understand survival rates and factors associated with lung cancer mortality in India. Methods: It was a hospital-based registry, wherein six hospitals were selected from three zones - north, central, and south zones of Kerala. Patients of pathologically proven primary lung cancer (ICD-11 code C 33 and C 36) were recruited. All patients were followed up for 2 years from the date of diagnosis. Results: A total of 761 patients were registered from six tertiary care hospitals of Kerala who were diagnosed with primary lung cancer during the period 2017-2019. The median survival of the study population was 8.6 months (IQR 2.9-21.6). The cumulative mortality rates at the end of 6 months, 1 year, and 2 years were 39.9%, 57.8%, and 70.2%, respectively. The overall mortality rate was 6.38 (CI 3.03-12.97) per 100 person months. In adjusted Cox-proportional hazard model, participants with lymph node status of N2 (HR = 4.9, 95% CI 1.0-23.6), N3 (HR = 5.9, 95% CI 0.53-66.7), and NX (HR = 31.7, 95% CI 2.8-354.7) had higher mortality risk compared to those with N1 status. Conclusion: This study includes significant implications for policy in cancer diagnosis and first health system contact for treatment. Findings are crucial to effectively stratify risk in lung cancer beyond smoking history, comprehensive identification, and assessment of potential predictors of mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.